File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.lrr.2017.02.002
- Scopus: eid_2-s2.0-85014158678
- PMID: 28331798
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Aspirin and risk of multiple myeloma in adults: A systematic review and meta-analysis
| Title | Aspirin and risk of multiple myeloma in adults: A systematic review and meta-analysis |
|---|---|
| Authors | |
| Keywords | Analgesics Meta-analysis Multiple myeloma Aspirin Neoplasms |
| Issue Date | 2017 |
| Citation | Leukemia Research Reports, 2017, v. 7, p. 23-28 How to Cite? |
| Abstract | Multiple myeloma is a relatively uncommon plasma cell malignancy. Preclinical and clinical studies have suggested that aspirin might modify the risk of multiple myeloma. We performed a systematic review and meta-analysis of studies to examine the association between regular aspirin use and risk of multiple myeloma. Five observational studies including 332,660 adults were evaluated. The pooled estimate had a hazard ratio of 0.90 (95% confidence interval =0.58−1.39; P=0.638). Odds ratios from the two case-control studies were similar. The findings demonstrated that there was no significant association between aspirin use and the risk of multiple myeloma. |
| Persistent Identifier | http://hdl.handle.net/10722/303512 |
| ISSN | 2023 Impact Factor: 0.7 2023 SCImago Journal Rankings: 0.299 |
| PubMed Central ID |
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Lee, Shing Fung | - |
| dc.contributor.author | Ng, Ting Ying | - |
| dc.contributor.author | Wong, Frank Chi Sing | - |
| dc.contributor.author | Tung, Stewart Yuk | - |
| dc.date.accessioned | 2021-09-15T08:25:28Z | - |
| dc.date.available | 2021-09-15T08:25:28Z | - |
| dc.date.issued | 2017 | - |
| dc.identifier.citation | Leukemia Research Reports, 2017, v. 7, p. 23-28 | - |
| dc.identifier.issn | 2213-0489 | - |
| dc.identifier.uri | http://hdl.handle.net/10722/303512 | - |
| dc.description.abstract | Multiple myeloma is a relatively uncommon plasma cell malignancy. Preclinical and clinical studies have suggested that aspirin might modify the risk of multiple myeloma. We performed a systematic review and meta-analysis of studies to examine the association between regular aspirin use and risk of multiple myeloma. Five observational studies including 332,660 adults were evaluated. The pooled estimate had a hazard ratio of 0.90 (95% confidence interval =0.58−1.39; P=0.638). Odds ratios from the two case-control studies were similar. The findings demonstrated that there was no significant association between aspirin use and the risk of multiple myeloma. | - |
| dc.language | eng | - |
| dc.relation.ispartof | Leukemia Research Reports | - |
| dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
| dc.subject | Analgesics | - |
| dc.subject | Meta-analysis | - |
| dc.subject | Multiple myeloma | - |
| dc.subject | Aspirin | - |
| dc.subject | Neoplasms | - |
| dc.title | Aspirin and risk of multiple myeloma in adults: A systematic review and meta-analysis | - |
| dc.type | Article | - |
| dc.description.nature | published_or_final_version | - |
| dc.identifier.doi | 10.1016/j.lrr.2017.02.002 | - |
| dc.identifier.pmid | 28331798 | - |
| dc.identifier.pmcid | PMC5348598 | - |
| dc.identifier.scopus | eid_2-s2.0-85014158678 | - |
| dc.identifier.volume | 7 | - |
| dc.identifier.spage | 23 | - |
| dc.identifier.epage | 28 | - |